Website
Since the start of the PaediatricData.EU website in 2015, the mission is to promote progress of medical research and treatment development.
The website was created to present ideas about how to evaluate the progress in treating children with a serious disease, in particular children with cancer. This is done to more quantitatively inform further policies for children by showing how changes proposed by established stakeholders translate into change in practices. For children with cancer, progress in outcomes is a long-standing issue. Children require specific medicines for their specific diseases, and children's interests have to be addressed through research that includes them and is specifically relevant for them. Examples of potential indicators described in this website show the complexities in improving outcomes for children and in measuring progress.
Over time, the mission has broadened beyond children and cancer to providing tools and to advancing regulatory science, for all persons and public health. Feedback and suggestions are welcome and invited with the form below.
Author
Ralf Herold MD PhD (ORCID) is since 2023 head of EMA’s Regulatory Science and Academia Workstream, in the Regulatory Science and Innovation Taskforce, where his team coordinates engagement with the academic sector, not-for-profit organisations and research institutions. He worked as senior scientific officer on paediatric medicines, oncology and foresight at the EMA from 2007-2017 and 2018-2023. From 2017 to 2018, he was the Pediatric development leader at Bayer AG Regulatory affairs and an ICH E11A expert group member. At Charité — Universitätsmedizin Berlin from 1994 to 2007, he obtained an experimental research PhD, board certified in paediatric and adolescent medicine, trained in paediatric oncology and haematology, and managed a national research network.